Cargando...
The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
Traditionally, phase II cancer trials test a binary endpoint formed from a dichotomisation of the continuous change in tumour size. Directly testing the continuous endpoint provides considerable gains in power, although also results in several statistical issues. One such issue is when complete resp...
Guardado en:
| Publicado en: | Stat Methods Med Res |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4668774/ https://ncbi.nlm.nih.gov/pubmed/22179821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0962280211432192 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|